Showing results (111-120 of 655) with videos related to

Sort By:
Pageof 66
Journal of Managed Care Pharmacy : JMCP|March 8, 2007
Merging P4P and disease management: how do you know which one is working?Allen L Smith
Journal of Managed Care Pharmacy : JMCP|April 5, 2007
Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical dataChristopher Bell, Jonathan Graham, Stephanie Earnshaw, et al.
Journal of Managed Care Pharmacy : JMCP|April 21, 2006
Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headachesOlga E Gershovich, Sarah J Billups, Thomas Delate, et al.
Journal of Managed Care Pharmacy : JMCP|June 4, 2010
Intervention to increase the proportion of acute myocardial infarction or coronary artery bypass graft patients receiving an order for aspirin at hospital dischargeMarcia L Brackbill, Vanessa T Kline, Christine S Sytsma, et al.
Journal of Managed Care Pharmacy : JMCP|July 20, 2010
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasisJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Pharmacoeconomic benefits of antihypertensive therapyEdgar R Gonzalez
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Initiation of statins after hospitalization for coronary heart diseaseXin Ye, Cynthia R Gross, Jon Schommer, et al.
Journal of Managed Care Pharmacy : JMCP|September 19, 2007
Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorderMark Olfson, Steven C Marcus, Huabin F Zhang, et al.
Journal of Managed Care Pharmacy : JMCP|March 7, 2006
Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literatureJennifer M Stephens, Marc F Botteman, Joel W Hay
Pageof 66